Timing of debridement, antibiotics, and implant retention (DAIR) for early post-surgical hip and knee prosthetic joint infection (PJI) does not affect 1-year re-revision rates: data from the Dutch Arthroplasty Register by Ende, Barry et al.
J. Bone Joint Infect., 6, 329–336, 2021
https://doi.org/10.5194/jbji-6-329-2021
© Author(s) 2021. This work is distributed under
the Creative Commons Attribution 4.0 License.
    Journal of Bone
and Joint Infection










Timing of debridement, antibiotics, and implant retention
(DAIR) for early post-surgical hip and knee prosthetic
joint infection (PJI) does not affect 1-year re-revision
rates: data from the Dutch Arthroplasty Register
Barry van der Ende1, Jakob van Oldenrijk1, Max Reijman1, Peter D. Croughs2,
Liza N. van Steenbergen3, Jan A. N. Verhaar1, and P. Koen Bos1
1Department of Orthopaedic Surgery and Sport Medicine, Erasmus University Medical Center,
Rotterdam, 3000 CA, the Netherlands
2Department of Microbiology, Erasmus University Medical Center, Rotterdam, 3000 CA, the Netherlands
3Dutch Arthroplasty Register (Landelijke Registratie Orthopedische Implantaten),
’s Hertogenbosch, 5232 AD, the Netherlands
Correspondence: P. Koen Bos (p.k.bos@erasmusmc.nl)
Received: 16 May 2021 – Revised: 15 August 2021 – Accepted: 16 August 2021 – Published: 3 September 2021
Abstract. Debridement, antibiotics, and implant retention (DAIR) is a procedure to treat a periprosthetic joint
infection (PJI) after total hip arthroplasty (THA) or total knee arthroplasty (TKA). The timing between the
primary procedure and the DAIR is likely a determinant for its successful outcome. However, the optimal timing
of a DAIR and the chance of success still remain unclear. We aimed to assess the risk of re-revision within 1 year
after a DAIR procedure and to evaluate the timing of the DAIR in primary THA and TKA. We used data from
the Dutch Arthroplasty Register (LROI) and selected all primary THA and TKA in the period 2007–2016 which
underwent a DAIR within 12 weeks after primary procedure. A DAIR was defined as a revision for infection in
which only modular parts were exchanged. A DAIR was defined as successful if not followed by a re-revision
within 1 year after DAIR; 207 DAIRs were performed < 4 weeks after THA, of which 16 (8 %) received a
complete revision within 1 year. DAIR procedures performed between 4 and 12 weeks (n= 98) had a failure
rate of 9 % (n= 9). After TKA 126 DAIRs were performed in less than 4 weeks, of which 11 (9 %) received a
complete revision within 1 year; 83 DAIRs were performed between 4 and 12 weeks, of which 14 (17 %) were
revised.
There was no significant difference in 1-year re-revision rate after a DAIR procedure by timing of the DAIR
procedure for total hip and knee arthroplasty based on Dutch registry data.
1 Introduction
Periprosthetic joint infection (PJI) following hip and knee
replacement surgery is a catastrophic complication with an
incidence of 1 %–2 % (Zimmerli et al., 2004; Kuiper et al.,
2014; Sendi et al., 2017). With an increasing annual number
of total joint replacements, the absolute annual incidence of
PJI is increasing accordingly (Zimmerli et al., 2004; Kuiper
et al., 2014).
The leading treatment strategy for an acute postopera-
tive PJI is debridement, antibiotics, and implant retention or
“DAIR procedure” (Tsukayama et al., 1996; Zimmerli et al.,
2004; Toms et al., 2006; Kuiper et al., 2014; Sendi et al.,
2017) according to most guidelines. Exchange of modular
components as part of a DAIR procedure is recommended in
total hip arthroplasty (THA) as well as total knee arthroplasty
(TKA) (Qasim et al., 2017; Tsang et al., 2017; Parvizi et al.,
2019).
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A few retrospective series have described an implant re-
tention rate of 60 %–80 % 1 year after treatment of acute PJI
(Kuiper et al., 2013, 2014; Anagnostakos and Schmitt, 2014;
de Vries et al., 2016; Qasim et al., 2017; Tsang et al., 2017).
The group of Trampuz suggested that DAIR is the preferred
treatment of an acute PJI only within the first 4 weeks after
joint replacement, according to biofilm theory (Izakovicova
et al., 2019), whilst according to de Vries et al. (2016), risk
of revision surgery is increased in case DAIR is performed
later than 3 months after index surgery for both THA and
TKA. However, in a retrospective study of 89 PJIs, Geurts et
al. (2013) showed that implants could be preserved in 50 %
of patients when the DAIR procedure was performed 8 weeks
after joint replacement.
Clearly, a DAIR procedure for a PJI is effective shortly
after surgery. Whether it is also a viable option in patients
with a delayed presentation is unknown. Could implants be
preserved with a DAIR even up to 3 months? To find a more
pronounced relation between outcome of treatment and the
period between primary procedure and DAIR, a large number
of patients is needed which cannot be reached in a single
centre. Therefore, data from the Dutch Arthroplasty Register
(LROI) were studied.
In this study we aimed to determine the DAIR failure rate
within 1 year in patients who had a DAIR procedure within
4 weeks after a primary procedure compared to a DAIR pro-
cedure 4–12 weeks for acutely postoperative infected pri-
mary implants. Furthermore, independent risk factors for re-
revision after a DAIR procedure were examined.
2 Methods
The LROI is a nationwide population-based register that
has included information on arthroplasties in the Nether-
lands since 2007. The LROI was initiated by the Dutch Or-
thopaedic Association and the database has 100 % hospital
coverage for hip and knee arthroplasty, with a 99 % com-
pleteness for both primary total hip and primary total knee
arthroplasty (LROI, 2019). The LROI database contains in-
formation on patient, procedure, and arthroplasty character-
istics based on product numbers registered on the day of
surgery (van Steenbergen et al., 2015). Body mass index
(BMI) and smoking status were added to the LROI in 2014.
The vital status of all patients is obtained actively on a regular
basis from Vektis, the national insurance database on health-
care in the Netherlands, which records all deaths of Dutch
citizens (http://www.Vektis.nl, last access: 29 October 2018).
The LROI uses the opt-out system to require informed con-
sent of patients.
For the present study we included all primary THAs and
TKAs for osteoarthritis in the period 2007–2016, which were
partially revised within 12 weeks after the primary implanta-
tion for infection or the suspicion thereof. A partial revision
was defined here as a revision procedure where at least the
femoral head (with or without the acetabular liner) in THA
or the insert in TKA were exchanged. With this definition
based on the LROI we presumed to include all patients un-
dergoing a DAIR with exchange of modular components for
acute PJI registered in the LROI.
We divided both hip and knee DAIR procedures into two
groups according to time between index surgery and DAIR
procedure. Group A underwent a DAIR procedure within
4 weeks, Group B between 4 and 12 weeks after the index
procedure.
We defined failure of a DAIR procedure as a complete re-
revision within 1 year after the DAIR procedure. A complete
revision was defined as the replacement or removal of all
components for any reason, as definitive treatment or as part
of either a single stage or multiple-stage revision.
For secondary analysis we used any type of revision within
1 year, including repeat-DAIR procedures.
2.1 Statistical analysis
Chi-squared tests were performed to test any differences in
failure of DAIR procedures between the two time period
groups, stratified by joint. Multivariable logistic regression
analysis was performed to examine independent risk factors
for re-revision after a DAIR procedure. The dependent vari-
able was failure of a DAIR procedure within 1 year, and in-
dependent variables were age, gender, American Society of
Anesthesiologists (ASA) classification, and type of fixation
(SPSS 22.0; IBM Corp., Armonk, NY, USA).
P values below 0.05 were considered statistically signif-
icant. For the 95 % confidence intervals (CIs), we assumed
that the number of observed cases followed a Poisson distri-
bution.
2.2 Potential conflicts of interest and statement of ethics
Our study was approved by the scientific advisory board of
the LROI. The dataset was processed according to LROI reg-
ulations on research using registry data. Ethical approval was
not requested, since these data were collected as part of the
usual (evaluation of) care process. No funding was received
and no conflicts of interests were declared. All the authors
contributed equally.
3 Results
Between 1 January 2007 and 31 December 2016, 514 pa-
tients fulfilled the inclusion criteria for a DAIR procedure:
305 after a primary THA and 209 after a primary TKA
(Fig. 1). In the THA group, 18 (5.9 %) deaths were regis-
tered, of which 4 (1.3 %) occurred within 1 year after a DAIR
procedure. In the TKA group, 10 (4.8 %) deaths were regis-
tered during our study period, of which 5 (2.4 %) were within
1 year after a DAIR procedure. None of these patients had
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Figure 1. Patient flow.
Table 1. Patient characteristics of the study population during the
primary procedure (n= 514).
THA TKA
(n= 305) (n= 209)
Age (years) (mean, SD) 69 (10) 69 (10)
Gender (n, %) female 163 (53) 88 (42)
ASA classification (n, %)
ASA I 42 (14) 34 (16)
ASA II 199 (65) 126 (60)
ASA III–IV 62 (20) 47 (23)
BMI category (n, %)
Underweight (< 18.5 kg/m2) 1 (0.3) –
Normal (18.5–25) 42 (14) 27 (13)
Overweight (25–30) 111 (36) 67 (32)
Obesity (30–40) 110 (36) 60 (29)
Morbid obesity (> 40) 12 (4) 12 (6)
Smoking (n, %)
Yes 32 (11) 18 (9)
No 227 (74) 130 (62)
Type of fixation (n, %)
Cemented 100 (33) 201 (96)
Uncemented 155 (51) 5 (2)
Hybrid 50 (16) 3 (1)
BMI: body mass index. ASA classification: American Society of
Anesthesiologists physical status classification. NB: numbers do not add up
to the total due to missing data, BMI, and smoking registered since 2014.
undergone a re-revision prior to death. They were excluded
from further analysis.
Patient characteristics for THA and TKA with a subse-
quent DAIR procedure were comparable, with an average
age of 69 years (Table 1).
Figure 2. Trend of DAIRs (with modular component exchange)
registered per year in the LROI (x axis: year in which procedure
was registered, y axis: number of DAIRs registered).
The number of registered DAIR procedures with modular
component exchange has gradually increased since 2007. Up
to 2011, less than 10 DAIR procedures per year were regis-
tered after THA and TKA each nationwide. These numbers
increased to 48 (16 %) in 2014 up to 131 (43 %) in 2016 for
THA. For TKA the number of registered DAIRs increased to
32 (15 %) in 2014 and up to 76 (36 %) TKAs in 2016 (Fig. 2).
The large majority (91 % in THA and 82 % in TKA) of
re-revisions within 1 year were performed for infection. Dis-
location, periprosthetic fracture, and loosening of the acetab-
ular component were alternative reasons for revision in 9 %
of cases in THA. In TKA other reasons for re-revision were
loosening, instability or malalignment, and arthrofibrosis.
3.1 Total hip arthroplasties
There were 207 THA patients that underwent a DAIR pro-
cedure within 4 weeks after index surgery (Group A) and 98
patients between 4 and 12 weeks (Group B) (Table 2).
A complete revision (exclusive repeat-DAIR procedure)
rate of 8 % (n= 16) was found in Group A and 9 % (n= 9)
in Group B (Fig. 3). When repeat-DAIR procedures were
included, in Group A 20 % (n= 41) received a re-revision
within 1 year, in Group B 17 % (n= 17) (Fig. 4).
Male gender showed an increased risk of a complete re-
revision, with an OR of 2.6 (CI 1.2–5.5) and an odds ratio
of 3.1 (CI 1.7–5.7) when repeat-DAIR procedures are in-
cluded. Neither ASA class, age, nor type of fixation were
significantly associated with the primary endpoint (Table 2).
3.2 Total knee arthroplasties
After TKA, 126 DAIR procedures were performed within
4 weeks (Group A) and 83 DAIRs were performed after 4–
12 weeks (Group B) (Table 3).
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Table 2. Number of re-revisions after DAIR procedures with odd ratios for different timings of DAIR after primary THA.
Complete revision OR (CI) Re-revision < 1 year OR (CI)
< 1 year (incl. repeat-DAIR)
DAIR < 4 weeks (n= 207) 16 (8 %) Ref∗ 41 (20 %) Ref
DAIR 4–12 weeks (n= 98) 9 (9 %) 1.2 (0.5–2.9) 17 (17 %) 0.9 (0.5–1.6)
Total 25 (8 %) 58 (19 %)
ASA class
ASA I (n= 42) 5 (12 %) 0.8 (0.2–3.8) 6 (14 %) 0.3 (0.1–1.9)
ASA II (n= 199) 23 (12 %) Ref 43 (22 %) Ref
ASA III–IV (n= 62) 4 (6 %) 0.3 (0.1–1.8) 8 (13 %) 0.4 (0.1–2.4)
Gender
Female (n= 163) 11 (7 %) Ref 18 (11 %) Ref
Male (n= 140) 22 (16 %) 2.6 (1.2–5.5) 39 (28 %) 3.1 (1.7–5.7)
Age (years)
< 70 (n= 164) 20 (12 %) Ref 37 (23 %) Ref
> 70 (n= 141) 13 (9 %) 0.7 (0.4–1.5) 21 (15 %) 1.5 (0.8–2.8)
Type of fixation
Cemented (n=100) 9 (9 %) Ref 14 (14 %) Ref
Uncemented (n=155) 19 (12 %) 1.4 (0.6–3.3) 37 (24 %) 1.8 (0.9–3.5)
Hybrid (n= 50) 5 (10 %) 1.0 (0.3–3.2) 7 (14 %) 0.9 (0.3–2.4)
∗ Ref: OR reference group; numbers do not add up to the total due to missing data.
Figure 3. Percentage of complete revision within 1 year when DAIR is performed for acute postoperative PJI < 4 weeks after primary
surgery or between 4 and 12 weeks. Blue graph for THA and green for TKA.
In Group A the number of patients undergoing a com-
plete revision was 9 % (n= 11) compared to 17 % (n= 14)
in Group B, which did not show a statistically significant dif-
ference (Fig. 3). In Group A 27 patients (21 %) received a re-
revision (including repeat-DAIRs) within 1 year, in Group B
17 (20 %) (Fig. 4).
No independent risk factor (ASA score, gender, age, or
type of fixation) could be identified, resulting in an increased
risk of re-revision (Table 3).
We pooled data for both THA and TKA DAIR proce-
dures, showing an 8 % complete revision rate when DAIR
was within 4 weeks and 13 % when DAIR was within 4–
12 weeks. Including repeat-DAIR procedures, the re-revision
rate for the group < 4 weeks was 20 %, and for the group 4–
12 weeks it was 19 %. There was no significant difference
between groups in the pooled data.
4 Discussion
In our observational LROI data analysis, we did not find an
increase in DAIR failure rate when a DAIR is performed be-
tween 4 weeks and up to 12 weeks after primary surgery for
early hip or knee arthroplasty PJI.
J. Bone Joint Infect., 6, 329–336, 2021 https://doi.org/10.5194/jbji-6-329-2021
B. van der Ende et al.: DAIR for early post-surgical hip and knee PJI does not affect 1-year re-revision rates 333
Figure 4. Percentage of re-revision including repeat-DAIR procedure within 1 year when DAIR is performed for acute postoperative PJI
< 4 weeks after primary surgery or between 4 and 12 weeks. Blue graph for THA and green for TKA.
Table 3. Number of re-revisions after DAIR procedures with odd ratios for different timings of DAIR after primary TKA.
Complete revision OR (CI) Re-revision < 1 year OR (CI)
< 1 year (incl. repeat-DAIR)
DAIR < 4 weeks (n= 126) 11 (9 %) Ref∗ 27 (21 %) Ref
DAIR 4–12 weeks (n= 83) 14 (17 %) 2.1 (0.9–4.9) 17 (20 %) 0.9 (0.5–1.9)
Total 25 (12 %) 44 (21 %)
ASA class
ASA I (n= 34) 1 (3 %) 0.2 (0.02–1.2) 6 (18 %) 0.7 (0.3–1.9)
ASA II (n= 126) 19 (15 %) Ref 28 (22 %) Ref
ASA III–IV (n= 47) 9 (19 %) 1.4 (0.6–3.3) 9 (19 %) 0.8 (0.4–1.9)
Gender
Female (n= 88) 11 (13 %) Ref 14 (16 %) Ref
Male (n= 121) 19 (16 %) 1.2 (0.6–2.8) 30 (25 %) 1.7 (0.8–3.4)
Age
< 70 (n= 116) 17 (15 %) Ref 25 (22 %) Ref
> 70 (n= 93) 13 (14 %) 1.1 (0.5–2.4) 19 (20 %) 1.1 (0.5–2.1)
Type of fixation
Cemented (n= 201) 19 (9 %) Ref 42 (21 %) Ref
Uncemented (n= 5) 0 (0 %) – 1 (20 %) 0.9 (0.1–8.1)
Hybrid (n= 3) 0 (0 %) – 1 (33 %) 1.8 (0.2–20.0)
∗ Ref: OR reference group; numbers do not add up to the total due to missing data.
The Dutch national implant registry data do not sup-
port the theory that a DAIR procedure can only treat a PJI
when performed within 4 weeks after primary surgery. We
could not show that the success of a DAIR procedure de-
creases when a larger interval exists between DAIR and pri-
mary procedure (Izakovicova et al., 2019). Our findings were
supported by the recently published retrospective study by
Löwik et al. (2020) including 769 PJIs.
Based on the discussion in the literature on the definition
of acute implant infections (Tsukayama et al., 1996; Zim-
merli et al., 2004; Toms et al., 2006), ranging from up to 3–
4 weeks to 3 months, we decided to use a study period rang-
ing from 0 to 12 weeks. We excluded acute hematogenous
infections since these patients cannot be identified due to
the limited detailed information in registries regarding infec-
tions. Infection was the reason for re-revision after a DAIR
procedure in 91 % of the cases for hip replacement and in
82 % for knee replacement. In the total hip population there
were two cases with acetabular loosening as the reason for
a re-revision, although low-grade infection could be an al-
ternative explanation for this early loosening. The same can
be said about the cases with loosening of a component or
arthrofibrosis in the total knee group. We considered all com-
plete revisions for any reason to be an implant failure.
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Because of deaths, 5 %–6 % of patients were excluded
from analysis; cause of death is unknown in the LROI. To
prove there is no exclusion bias influencing our results, we
performed a sensitivity analysis with a worst-case scenario,
with every death scoring as a complete revision. This analy-
sis shows an OR of 1.3 (CI 0.7–2.5) when DAIR is performed
> 4 weeks after THA and an OR 1.8 (CI 0.9–3.6) > 4 weeks
after TKA, which corresponds to our findings.
We performed this study to investigate the success or fail-
ure rate of a DAIR procedure after primary knee and hip re-
placement in association with timing. The data were selected
with a number of assumptions. We trust the considerations
by the treating orthopaedic surgeon to perform a DAIR pro-
cedure based on a grounded suspicion of a PJI and the as-
sumption of correct registration of procedures. By selecting
DAIR procedures from the LROI, we selected only DAIR
procedures in which an exchange of modular components
was performed. In total knee replacements this means an ex-
change of the insert, and in total hip replacements this means
an exchange of the femoral head and/or acetabular liner. The
results presented in this study are only applicable for DAIR
procedures with modular component exchange.
The ideal approach in our retrospective study would be to
include the investigated variable (time to DAIR) in a multi-
variate model with other co-variates with a known influence
on revision rate (like for instance significant co-morbidity
such as rheumatoid arthritis, chronic renal impairment, im-
munosuppressant therapy, or antibiotics used). However, the
registry only includes information regarding gender, BMI,
and age, which is a limitation.
We observed a trend of increased component exchange
during DAIR procedures. A nationwide Dutch survey
showed that 82 % out of 99 institutions exchanged the in-
sert during a DAIR procedure for a TKA infection (Veltman
et al., 2018). In THA, 66 out of 99 institutions exchanged all
modular parts during a DAIR procedure, 8 institutions rou-
tinely exchanged the femoral head only, and 3 exchanged
modular parts routinely during the second DAIR procedure
(Veltman et al., 2018). As a consequence, the authors showed
that 63 % of institutions registered DAIR procedures in the
LROI database (Veltman et al., 2018). Some surgeons may
choose not to change the modular components, either to pre-
vent additional damage to the component or based on insuf-
ficient evidence supporting the exchange of modular compo-
nents during PJI treatment.
The increasing number of DAIRs being registered over
the years in the Dutch registry is most probably explained
by the increased awareness of the importance of exchanging
the modular components in the literature and (inter)national
guidelines. Modular component exchange is shown to have a
positive effect on the success rate of DAIR procedures (Ar-
genson et al., 2019; Lora-Tamayo et al., 2013).
The percentage of re-revisions after DAIR procedures is
for both total hip and knee arthroplasty around 20 % in our
analysis. This number is in accordance with general results
after DAIR procedures in the literature, with a success rate of
60 %–80 % (Tsukayama et al., 1996; Zimmerli et al., 2004;
Toms et al., 2006; Kuiper et al., 2014; Sendi et al., 2017), and
does not differ between groups.
We showed no clear increased re-revision rate after DAIR
for all patient characteristics except for male gender after
THA. The observed male gender effect in our analysis may
be explained by the general increased risk of PJI develop-
ment in men, as described in the systematic literature review
in 2016 by Kunutsor et al. (2016). Perhaps this also explains
an increased risk of PJI in post-DAIR patients. Using a ce-
mented or cementless prosthesis does not seem to influence
the risk of DAIR failure. We did not make a distinction be-
tween antibiotic-loaded or antibiotic-unloaded cement, be-
cause the majority (> 94 %) of cemented prostheses regis-
tered in the LROI were implanted using gentamicin-loaded
cement for both THA and TKA (LROI, 2019).
Results in our study can be influenced by unknown con-
founders such as unknown patient characteristics and the
difference in causative microbiological agent and antibiotic
regimes following DAIR in different institutions. We as-
sume that the clinical decision to perform a DAIR procedure
has been made according to known guidelines and a well-
substantiated diagnosis of a PJI given. Some treatment proto-
cols may use a standard second DAIR procedure; this might
have influenced our results.
To conclude, based on Dutch Arthroplasty Register data,
regarding acutely infected total hip or knee arthroplasties,
we were not able to show a difference in re-revision rates
for DAIR procedures performed within 4 weeks or between
4 and 12 weeks with 1-year follow-up. In delayed presenta-
tions of an acute postoperative PJI, a DAIR procedure may
be a viable treatment to preserve the implant at least up to
3 months.
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